Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Dahlén

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Chemistry and Physics of Lipids|September 1, 1977
The crystal structure of cholesteryl 17-bromoheptadecanoateS Abrahamsson, B Dahlén
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 16, 2000
The challenge procedure influences the extent of allergen-induced urinary excretion of leukotriene E4M Kumlin, B Dahlén
The European Respiratory Journal|May 1, 1990
Comparison of bronchial and per oral provocation with aspirin in aspirin-sensitive asthmaticsB Dahlén, O Zetterström
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 30, 2013
High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experienceT Gülen, H Hägglund, B Dahlén, et al.
Journal of Internal Medicine|September 9, 2015
Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic diseaseT Gülen, H Hägglund, B Dahlén, et al.
The Journal of Allergy and Clinical Immunology|August 1, 1996
Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstructionS O'Sullivan, B Dahlén, S E Dahlén, et al.
The European Respiratory Journal|February 1, 1994
The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmaticsB Dahlén, O Zetterström, T Björck, et al.
Allergy|January 22, 2013
The antimicrobial peptide LL-37 induces synthesis and release of cysteinyl leukotrienes from human eosinophils--implications for asthmaJ Sun, B Dahlén, B Agerberth, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 22, 2014
The presence of mast cell clonality in patients with unexplained anaphylaxisT Gülen, H Hägglund, B Sander, et al.
Thorax|December 1, 1993
Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjectsB Dahlén, D J Margolskee, O Zetterström, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Chemistry and Physics of Lipids|September 1, 1977
The crystal structure of cholesteryl 17-bromoheptadecanoateS Abrahamsson, B Dahlén
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 16, 2000
The challenge procedure influences the extent of allergen-induced urinary excretion of leukotriene E4M Kumlin, B Dahlén
The European Respiratory Journal|May 1, 1990
Comparison of bronchial and per oral provocation with aspirin in aspirin-sensitive asthmaticsB Dahlén, O Zetterström
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 30, 2013
High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experienceT Gülen, H Hägglund, B Dahlén, et al.
Journal of Internal Medicine|September 9, 2015
Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic diseaseT Gülen, H Hägglund, B Dahlén, et al.
The Journal of Allergy and Clinical Immunology|August 1, 1996
Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstructionS O'Sullivan, B Dahlén, S E Dahlén, et al.
The European Respiratory Journal|February 1, 1994
The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmaticsB Dahlén, O Zetterström, T Björck, et al.
Allergy|January 22, 2013
The antimicrobial peptide LL-37 induces synthesis and release of cysteinyl leukotrienes from human eosinophils--implications for asthmaJ Sun, B Dahlén, B Agerberth, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 22, 2014
The presence of mast cell clonality in patients with unexplained anaphylaxisT Gülen, H Hägglund, B Sander, et al.
Thorax|December 1, 1993
Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjectsB Dahlén, D J Margolskee, O Zetterström, et al.
Pageof 5